Speech-Language Pathologists in Brattleboro, VT Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Shine Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 High St Ste 101, Brattleboro, VT 05301 Phone: 802-258-7115

Sarah Shine, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Main St, 2nd Floor, Brattleboro, VT 05301 Phone: 802-258-7115

Francine Freeman, M.ED, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Austine Dr, Brattleboro, VT 05301 Phone: 802-257-2101

Catharine M Hamilton, MA, CCC-SLP, CAGS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 High St, Suite 101, Brattleboro, VT 05301 Phone: 802-258-7115

Patricia Mcpike, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 193 Sunset Lake Rd, Brattleboro, VT 05301 Phone: 802-257-4759

News Archive

Positive lifestyle changes could reduce risk of developing cancer

There are many factors that determine your likelihood of developing cancer, including age, genetic predisposition and lifestyle.

Study: ICE detention centers experienced repeated outbreaks of vaccine-preventable illnesses

More than a dozen U.S. Immigration and Customs Enforcement (ICE) detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses in the last three years, according to a new study by researchers at UC San Francisco.

Biogen Idec offers to completely acquire Facet

Biogen Idec's interest in acquiring Facet was first conveyed on August 17, 2009 by Mr. Mullen to Faheem Hasnain, President and Chief Executive Officer of Facet.

Eli Lilly completes Alnara acquisition

Eli Lilly and Company today announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of metabolic diseases. The transaction, first announced on July 2, 2010, has received the approval of Alnara stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All other closing conditions have also been met.

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients.

Read more Medical News

› Verified 1 days ago